chr17-73348683-A-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001144952.2(SDK2):āc.6081T>Gā(p.Asp2027Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000411 in 1,459,500 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 0.0000041 ( 0 hom. )
Consequence
SDK2
NM_001144952.2 missense
NM_001144952.2 missense
Scores
4
5
10
Clinical Significance
Conservation
PhyloP100: -0.246
Genes affected
SDK2 (HGNC:19308): (sidekick cell adhesion molecule 2) The protein encoded by this gene is a member of the immunoglobulin superfamily. The protein contains two immunoglobulin domains and thirteen fibronectin type III domains. Fibronectin type III domains are present in both extracellular and intracellular proteins and tandem repeats are known to contain binding sites for DNA, heparin and the cell surface. This protein, and a homologous mouse sequence, are very similar to the Drosophila sidekick gene product but the specific function of this superfamily member is not yet known. Evidence for alternative splicing at this gene locus has been observed but the full-length nature of additional variants has not yet been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.23643598).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SDK2 | NM_001144952.2 | c.6081T>G | p.Asp2027Glu | missense_variant | 44/45 | ENST00000392650.8 | NP_001138424.1 | |
SDK2 | XM_011524914.3 | c.6024T>G | p.Asp2008Glu | missense_variant | 43/44 | XP_011523216.1 | ||
SDK2 | XM_011524915.3 | c.6081T>G | p.Asp2027Glu | missense_variant | 44/46 | XP_011523217.1 | ||
SDK2 | XM_047436313.1 | c.6024T>G | p.Asp2008Glu | missense_variant | 43/45 | XP_047292269.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SDK2 | ENST00000392650.8 | c.6081T>G | p.Asp2027Glu | missense_variant | 44/45 | 5 | NM_001144952.2 | ENSP00000376421 | P1 | |
SDK2 | ENST00000424778.1 | c.3552T>G | p.Asp1184Glu | missense_variant | 26/27 | 5 | ENSP00000407098 | |||
SDK2 | ENST00000410094.5 | n.1154T>G | non_coding_transcript_exon_variant | 9/10 | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.0000200 AC: 5AN: 249476Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 134920
GnomAD3 exomes
AF:
AC:
5
AN:
249476
Hom.:
AF XY:
AC XY:
4
AN XY:
134920
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000411 AC: 6AN: 1459500Hom.: 0 Cov.: 31 AF XY: 0.00000689 AC XY: 5AN XY: 726034
GnomAD4 exome
AF:
AC:
6
AN:
1459500
Hom.:
Cov.:
31
AF XY:
AC XY:
5
AN XY:
726034
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 12, 2021 | The c.6081T>G (p.D2027E) alteration is located in exon 44 (coding exon 44) of the SDK2 gene. This alteration results from a T to G substitution at nucleotide position 6081, causing the aspartic acid (D) at amino acid position 2027 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Pathogenic
D;D
Sift4G
Pathogenic
D;D
Polyphen
B;.
Vest4
MutPred
Gain of methylation at K2032 (P = 0.1188);.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at